Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_assertion type Assertion NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_head.
- NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_assertion description "[We tested the effect of pan-class I PI3K inhibition by siRNA silencing or pharmacologic inhibition with buparlisib on MM cell survival, apoptosis and cell cycle in vitro and tumor growth and mobilization of MM cells in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_provenance.
- NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_assertion evidence source_evidence_literature NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_provenance.
- NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_assertion SIO_000772 25060991 NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_provenance.
- NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_assertion wasDerivedFrom befree-20150227 NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_provenance.
- NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_assertion wasGeneratedBy ECO_0000203 NP623875.RAqlfm96Lq2PBBPH05slhDBlB3JYu0b0RADWtVpy3El-0130_provenance.